Literature DB >> 3525861

The mechanism of human bladder tumor implantation in an in vitro model.

D Pode, Y Alon, A T Horowitz, I Vlodavsky, S Biran.   

Abstract

Implantation of tumor cells in the bladder following transurethral resection of superficial bladder tumors is believed to be one factor in the etiology of bladder tumor recurrences. Using an in vitro model system we have studied the initial interaction between bladder carcinoma cells and a naturally produced basement membrane-like substrate. Minced explants of superficial low grade human bladder tumors from 10 patients were plated into culture dishes coated with a naturally produced extracellular matrix (ECM). This ECM has been shown to resemble the human urothelial basement membrane and submucosa in its macromolecular composition and ultrastructural appearance. It was found that a firm attachment of the human bladder tumor cells occurred within one hour, reached a maximal value within 24 hours and was followed by flattening and proliferation of the plated cells. These results indicate that prevention of tumor implantation should be initiated in the first hour after transurethral resection of the bladder tumors. This assay can be used for the investigation of various treatments to prevent tumor implantation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3525861     DOI: 10.1016/s0022-5347(17)44926-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

Review 1.  [Early instillation in superficial bladder carcinoma. Current status].

Authors:  S Langbein; A Häcker; J K Badawi; M S Michel; P Alken
Journal:  Urologe A       Date:  2004-12       Impact factor: 0.639

2.  Indication of selective growth of human endometrial epithelial cells on extracellular matrix.

Authors:  A Birkenfeld; Y Ezra; N Ron; D Navot; S Granovsky; J G Schenker; I S Levij; I Vlodavsky
Journal:  In Vitro Cell Dev Biol       Date:  1988-12

3.  Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response.

Authors:  L R Kavoussi; E J Brown; J K Ritchey; T L Ratliff
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

4.  New developments in the management of nonmuscle invasive bladder cancer.

Authors:  Mark D Tyson; Daniel Lee; Peter Clark
Journal:  Curr Opin Oncol       Date:  2017-05       Impact factor: 3.645

5.  Morphological aspects of the interaction of Bacillus Calmette-Guérin with urothelial bladder cells in vivo and in vitro: relevance for antitumor activity?

Authors:  J S Teppema; E C de Boer; P A Steerenberg; A P van der Meijden
Journal:  Urol Res       Date:  1992

6.  Oncological safety and quality of life in men undergoing simultaneous transurethral resection of bladder tumor and prostate: results from a randomized controlled trial.

Authors:  Marco Dellabella; Alessandro Branchi; Luca Gasparri; Redi Claudini; Daniele Castellani
Journal:  World J Urol       Date:  2018-05-03       Impact factor: 4.226

7.  The efficacy and safety of simultaneous transurethral GreenLight photoselective vaporization of bladder tumor and prostate in patients with bladder tumor and lower urinary tract symptoms.

Authors:  Zhaoyi Li; Ruipeng Hou; Jian Li
Journal:  Int Urol Nephrol       Date:  2013-10-05       Impact factor: 2.370

8.  Inhibition of bladder tumor cell implantation in cauterized urothelium, without inhibition of healing, by a fibronectin-related peptide (GRGDS).

Authors:  L M Hyacinthe; T W Jarrett; C S Gordon; E D Vaughan; G F Whalen
Journal:  Ann Surg Oncol       Date:  1995-09       Impact factor: 5.344

9.  Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer.

Authors:  Stefanie Schmidt; Frank Kunath; Bernadette Coles; Desiree Louise Draeger; Laura-Maria Krabbe; Rick Dersch; Samuel Kilian; Katrin Jensen; Philipp Dahm; Joerg J Meerpohl
Journal:  Cochrane Database Syst Rev       Date:  2020-01-08

10.  Single early instillation of mitomycin C and urinary alkalinization in low-risk non-muscle-invasive bladder cancer: a preliminary study.

Authors:  Hamit Ersoy; Muhammet Yaytokgil; Ahmet Nihat Karakoyunlu; Hikmet Topaloglu; Levent Sagnak; Hakki Ugur Ozok
Journal:  Drug Des Devel Ther       Date:  2012-12-28       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.